NEW YORK (Reuters Health) Jul 17 –
While chronic hepatitis B virus (HBV) infection is a known risk factor for hepatocellular carcinoma, findings from a new study show that the risk is particularly high among subjects positive for hepatitis B e antigen (HBeAg).
However, the antigen itself is probably not a direct carcinogen, according to an accompanying editorial. Rather, the presence of HBeAg indicates that active viral replication is occurring, which is tied to an increased risk of cancer.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!